Dear Colleagues, 
 
In tandem with introducing new and advanced technology and equipment as our services develop, we have been establishing different Centres of Excellence to provide highly-specialised treatments. Recently, we have introduced to the media our new Peritoneal Malignancy Treatment (PMT) Centre. The first of its kind in Hong Kong specialising in treating peritoneal metastasis, the PMT Centre provides novel procedures including Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC). Since its launch last year, dozens of peritoneal cancer patients have undergone the treatments with excellent clinical outcomes. Statistics in the past couple of years tell us that the demand for cancer services is on the rise. Taking our Oncology Ward as an example, the number of cases managed last month was a double of the caseload handled a year ago. I attribute the growth and the trust gained from our patients to your effort in always putting patients first and providing the best quality of care. 
 
Oncology, Cardiology, General Surgery, Orthopaedics & Traumatology, and Obstetrics & Gynaecology will remain our service focus areas. Yet, this does not stop us from developing new services in other specialties. Our Skin & Laser Clinic has recently introduced MiraDry microwave ablation of sweat glands, a new procedure adopting patented non-invasive microwave technology for more effective treatment of hyperhidrosis. 
 
The Digital Subtraction Angiography (DSA) Suite launched earlier has allowed our doctors to perform various diagnostic and interventional procedures with 3D digital imaging technology. Just last week, our team performed the first urgent interventional radiology procedure for a patient who experienced severe uterine bleeding after a Cesarean delivery. Credit to our highly-responsive and efficient team, the patient was in a stable condition after a smooth and successful uterine artery embolisation.  
 
I am pleased to share with you that the new surgical robotic system in our operating theatre is undergoing its final stage of commissioning and trial run. With this new system, we are looking to progressively extend minimally-invasive surgeries to more specialties as to further raise our surgical capacity and provide more treatment options for patients. 
 
You may recall the Employee Engagement Survey (EES) you took part in last year. To assess the effectiveness of the post-survey actions taken in response to your feedback to the EES, we have invited all of you to participate in the 2021 Year-end Pulse Survey. I call for your active participation in the Survey to help us address your needs more closely and identify the areas that you would like more support from the hospital. Your views count, and together, we can make GHK a better workplace for everyone! 

Dr Kenneth Tsang 
Chief Executive Officer 

We are proud to have been awarded the Health Impact Award (Gold) at the Dutch Chamber of Commerce 30th Anniversary Business Award Ceremony for the positive impact that we have made to Hong Kong's healthcare through leading advancement in health-tech initiatives, providing high fee transparency, and contributing to the long-term development of our city’s healthcare professionals. 

Watch a short video sharing of our success story: